Latest Research
Ex vivo imaging-based high content phenotyping of patients with rheumatoid arthritis. January 2025
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis. Ann Rheum Dis. October 2024
Research Group of Stephan Blüml
We analyze the mechanisms leading to joint inflammation and subsequently joint destruction, with an emphasis on the contribution of myeloid cells in that process.
Research Group of Michael Bonelli
Advancing personalized medicine in Rheumatology
Research Group of Silvia Hayer
Inflammatory joint damage & bone biologyWe study pathomechanisms of inflammation-mediated joint damage and systemic bone loss.
Research Group of Leonhard Heinz
Research Group of Thomas Karonitsch
Fibroblast pathology in rheumatic diseasesOur group aims to unfold the mechanisms that drive FLS activation in inflammatory joint diseases. We focus on inflammatory and metabolic pathways (e.g. mTOR pathway) that are critical for the inflammatory response in FLS.
